Journal of Clinical Oncology Publishes Clinical Data for Cohort 2 in Iovance C-144-01 Study of Lifileucel TIL Therapy in Metastatic Melanoma

NEXT STORY
Predictive Oncology Reports Financial Results for Quarter Ended March 31, 2021 and Provides Business Update
PREV STORY
Enochian BioSciences announces Scientific Presentation of a Person with HIV Exhibiting Controlled Blood Levels of Virus for 255 Days Following Treatment with a Novel Cellular Therapy
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Journal of Clinical Oncology Publishes Clinical Data for Cohort 2 in Iovance C-144-01 Study of Lifileucel TIL Therapy in Metastatic Melanoma

NEXT STORY
Predictive Oncology Reports Financial Results for Quarter Ended March 31, 2021 and Provides Business Update
PREV STORY
Enochian BioSciences announces Scientific Presentation of a Person with HIV Exhibiting Controlled Blood Levels of Virus for 255 Days Following Treatment with a Novel Cellular Therapy
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Cullinan Oncology to Participate in the Evercore ISI 4th Annual HealthconX Conference

author_avatar
NASDAQ Market News

Insights on the Electronic Skin Patches Global Market to 2031 – Players Profiled Include VitalConnect, Sensium Healthcare and Quad Industries Among Others

author_avatar
NASDAQ Market News

FDA Approves Samsung Bioepis and Biogen’s BYOOVIZ™ (SB11), LUCENTIS® Biosimilar (ranibizumab-nuna)

author_avatar
NASDAQ Market News